Giulia Zigon

Employment

• GSK Vaccines SRL Associate Director
  2017 - Present
• Philogen SpA Biostatistician
  2009 - 2017
• Fondazione IRCCS Istituto Nazionale dei Tumori Biostatistician
  2006 - 2009

Education

• Università degli Studi di Firenze Phd in Applied Statistics
  2003 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial
  Infection & Chemotherapy 2026 DOI: 10.3947/ic.2026.0016
  +Save
• The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.
  Cell adhesion & migration 2015 DOI: 10.4161/19336918.2014.983785
  +Save
• Cancer estimates up to 2015 in Friuli Venezia Giulia.
  Tumori 2013 DOI: 10.1700/1334.14795
  +Save
• Estimates of cancer burden in Campania.
  Tumori 2013 DOI: 10.1700/1334.14802
  +Save
• Estimates of cancer burden in Sicily.
  Tumori 2013 DOI: 10.1700/1334.14805
  +Save
• Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study.
  Acta oncologica (Stockholm, Sweden) 2010 DOI: 10.3109/02841861003782009
  +Save
• Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study.
  Annals of oncology : official journal of the European Society for Medical Oncology 2010 DOI: 10.1093/annonc/mdq306
  +Save
• The cure of cancer: a European perspective.
  European journal of cancer (Oxford, England : 1990) 2009 DOI: 10.1016/j.ejca.2008.11.034
  +Save
• Survival for ethmoid sinus adenocarcinoma in European populations.
  Acta oncologica (Stockholm, Sweden) 2009 DOI: 10.1080/02841860902874755
  +Save
• Prostate cancer treatment in Europe at the end of 1990s.
  Acta oncologica (Stockholm, Sweden) 2009 DOI: 10.1080/02841860902719174
  +Save